Bray Capital Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $45.4K | Hold |
467
| – | – | 0.01% | 182 |
|
|
2024
Q3 | $53.7K | Hold |
467
| – | – | 0.01% | 177 |
|
|
2024
Q2 | $49.7K | Hold |
467
| – | – | 0.01% | 172 |
|
|
2024
Q1 | $45.2K | Hold |
467
| – | – | 0.01% | 180 |
|
|
2023
Q4 | $47.2K | Hold |
467
| – | – | 0.01% | 179 |
|
|
2023
Q3 | $47.6K | Hold |
467
| – | – | 0.01% | 175 |
|
|
2023
Q2 | $47.1K | Hold |
467
| – | – | 0.01% | 178 |
|
|
2023
Q1 | $43K | Hold |
467
| – | – | 0.01% | 187 |
|
|
2022
Q4 | $42.4K | Hold |
467
| – | – | 0.01% | 186 |
|
|
2022
Q3 | $35K | Hold |
467
| – | – | 0.01% | 199 |
|
|
2022
Q2 | $39K | Hold |
467
| – | – | 0.01% | 193 |
|
|
2022
Q1 | $41K | Hold |
467
| – | – | 0.01% | 201 |
|
|
2021
Q4 | $41K | Hold |
467
| – | – | 0.01% | 204 |
|
|
2021
Q3 | $38K | Hold |
467
| – | – | 0.01% | 200 |
|
|
2021
Q2 | $43K | Hold |
467
| – | – | 0.01% | 194 |
|
|
2021
Q1 | $40K | Hold |
467
| – | – | 0.01% | 195 |
|
|
2020
Q4 | $44K | Hold |
467
| – | – | 0.01% | 189 |
|
|
2020
Q3 | $41K | Hold |
467
| – | – | 0.01% | 184 |
|
|
2020
Q2 | $41K | Hold |
467
| – | – | 0.02% | 183 |
|
|
2020
Q1 | $39K | Hold |
467
| – | – | 0.02% | 178 |
|
|
2019
Q4 | $44K | Sell |
467
-51
| -10% | -$4.58K | 0.02% | 191 |
|
|
2019
Q3 | $45K | Hold |
518
| – | – | 0.02% | 185 |
|
|
2019
Q2 | $47K | Sell |
518
-60
| -10% | -$5.08K | 0.02% | 202 |
|
|
2019
Q1 | $50K | Buy |
578
+57
| +11% | +$4.58K | 0.02% | 199 |
|
|
2018
Q4 | $40K | Hold |
521
| – | – | 0.02% | 205 |
|
|
2018
Q3 | $40K | Hold |
521
| – | – | 0.02% | 211 |
|
|
2018
Q2 | $35K | Hold |
521
| – | – | 0.02% | 239 |
|
|
2018
Q1 | $38K | Buy |
+521
| New | +$39.7K | 0.02% | 228 |
|
|
2016
Q2 | – | Sell |
-3,758
| Closed | -$244K | – | 125 |
|
|
2016
Q1 | $244K | Hold |
3,758
| – | – | 0.21% | 75 |
|
|
2015
Q4 | $290K | Hold |
3,758
| – | – | 0.18% | 99 |
|
|
2015
Q3 | $309K | Hold |
3,758
| – | – | 0.2% | 98 |
|
|
2015
Q2 | $331K | Hold |
3,758
| – | – | 0.19% | 104 |
|
|
2015
Q1 | $332K | Sell |
3,758
-426
| -10% | -$37.8K | 0.2% | 109 |
|
|
2014
Q4 | $347K | Buy |
+4,184
| New | +$347K | 0.23% | 111 |
|
Other funds holding NVS
Bray Capital Advisors's NVS Position: Q4 2024 in Review
Bray Capital Advisors held its Novartis (NVS) position steady in Q4 2024 at 467 shares worth $45.4K. The position accounts for 0.01% of the portfolio, ranked #182.
Bray Capital Advisors first reported a position in NVS in Q4 2014 and has held it in 34 quarters since. The position peaked at $347K in Q4 2014. 1,340 funds tracked by Wall St. Rank hold NVS as of Q4 2024.
- Bray Capital Advisors held 467 shares of Novartis worth $45.4K as of Q4 2024.
- Bray Capital Advisors left its Novartis share count unchanged in Q4 2024.
- Novartis made up 0.01% of Bray Capital Advisors's portfolio in Q4 2024, its #182 holding.
- Bray Capital Advisors first reported a position in Novartis in Q4 2014 and has held it in 34 quarters since.
- Bray Capital Advisors's Novartis position peaked at $347K in Q4 2014.
- 1,340 funds tracked by Wall St. Rank held Novartis as of Q4 2024.
Based on Bray Capital Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.